COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 121: Articles 1201-1210  | Next

Cytokine and Lymphocyte Profiles in COVID-19 Patients with Cancer: Implications for Disease Severity and Clinical Outcomes
Burla, M. M., Silva, K. L., Peixoto, B. C., Goes, L. R., Azevedo-Quintanilha, I., Bozza, F. A., Soares, M. A., de Melo, A. C., Hottz, E. D., Bozza, P. T., Viola, J. P. B.
10.1101/2025.04.24.25326371 — Posted: 2025-04-25
Real-world effectiveness of NVX-CoV2373 COVID-19 vaccine in immunocompromised individuals in South Korea
Gwak, E., Choe, S.-A., Kim, K., Bolormaa, E., Gschwend, M. H., Fix, J., Vadivale, M., Rousculp, M. D., Choe, Y. J.
10.1101/2025.04.24.25326359 — Posted: 2025-04-25
Must Whatever Goes up Come Down? Mortality Gradients in the Emergence of COVID-19
Klein, J. D.
10.1101/2025.04.23.25326307 — Posted: 2025-04-25
Healthcare use in individuals with rheumatoid arthritis during the COVID-19 pandemic and beyond: A cohort study in three nations of the UK
Costello, R. E., Parker, M., Kennedy, J., Brophy, S., Mehrkar, A., Bacon, S., Goldacre, B., MacKenna, B., Evans, D., Tomlinson, L., Hollick, R., Humphreys, J.
10.1101/2025.04.25.25326408 — Posted: 2025-04-25
Spatiotemporal structure of SARS-CoV-2 mutational frequencies in wastewater samples from Ontario
Magbor, P., Wang, W. Z., Gugan, G., Olabode, A. S., Becker, D. G., Parreira, V. R., Lawal, O. U., Fedynak, A., Zhang, L., Rizvi, F., Precious, M., DeGroot, C. T., Goodridge, L., Poon, A. F. Y.
10.1101/2025.04.23.25326084 — Posted: 2025-04-25
Impact of self-administered pulse oximetry among non-hospitalized patients at risk of severe COVID-19 in Honduras: A pragmatic, block-randomized trial
Roberts, K. W., Alvarez, B., de St. Aubin, M., Diaz, O., Garnier, S., Schnorr, C. D., Cruz, S., Pavon, L., Ochoa, A., Medice, S., Santos, H. M., Ochoa, J., Solis, S., Dumas, D., Baldwin, M., Martinez, A., Nilles, E.
10.1101/2025.04.23.25326278 — Posted: 2025-04-25
Transmission dynamics of Norovirus GII and Enterovirus in Switzerland during the COVID-19 pandemic (2021-2022) as evidenced in wastewater
Huisman, J. S., Torii, S., Wynn, H. K., Gan, C., Voellmy, I. K., Huber, M., Julian, T. R., Kohn, T.
10.1101/2025.04.22.25326216 — Posted: 2025-04-24
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming
Milanesi, M., Urbinati, C., Zimmermann, L., Oreste, P., Zani, A., Caruso, A., Caccuri, F., Laketa, V., Chlanda, P., Wade, R. C., Rusnati, M., Paiardi, G.
10.1101/2025.04.23.650164 — Posted: 2025-04-24
COVID-19 in Space: Possible Health Risks and Preparedness Guidelines
Vashishat, I., Han, E., Assogba, B. D.
10.1101/2025.04.23.650113 — Posted: 2025-04-24
In Vitro and Viral Evolution Convergence Reveal the Selective Pressures Driving Omicron Emergence
Shoshany, A., Tian, R., Blanco, M. P., Hruska, A., Konar, A., Baxova, K., Zoler, E., Mokrejs, M., Schreiber, G., Zahradnik, J.
10.1101/2025.04.23.650148 — Posted: 2025-04-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).